Friday 25 December 2009

Dytuss Elixir


Pronunciation: DYE-fen-HYE-dra-meen
Generic Name: Diphenhydramine
Brand Name: Examples include Benadryl Allergy and Dytuss


Dytuss Elixir is used for:

Preventing or treating symptoms of hay fever and other upper respiratory allergies or the common cold, such as runny nose, sneezing, itching of the nose and throat, and itchy, watery eyes, and relieving cough. It may also be used for other conditions as determined by your doctor.


Dytuss Elixir is an antihistamine and anticholinergic. It works by blocking the action of histamine, reducing the symptoms of an allergic reaction. It also works in the brain to cause sedation.


Do NOT use Dytuss Elixir if:


  • you are allergic to any ingredient in Dytuss Elixir or other similar medicines

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dytuss Elixir:


Some medical conditions may interact with Dytuss Elixir. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a fast, slow, or irregular heartbeat

  • if you have a history of asthma; chronic obstructive pulmonary disease (COPD); chronic bronchitis; lung problems (eg, emphysema); shortness of breath; sleep apnea; heart blood vessel problems; stroke; seizures; a blockage of your stomach, intestine, or bladder; difficulty urinating; diabetes; ulcers; an enlarged prostate or other prostate problems; glaucoma; heart problems; high blood pressure; the blood disease porphyria; phenylketonuria; or an overactive thyroid

Some MEDICINES MAY INTERACT with Dytuss Elixir. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Sodium oxybate (GHB) because an increase in sleep duration and a decrease in the ability to breathe are likely to occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dytuss Elixir may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dytuss Elixir:


Use Dytuss Elixir as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Dytuss Elixir by mouth with or without food.

  • Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • Use Dytuss Elixir exactly as directed on the package, unless instructed differently by your doctor. If you are taking Dytuss Elixir without a prescription, follow any warnings and precautions on the label.

  • If you miss a dose of Dytuss Elixir and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dytuss Elixir.



Important safety information:


  • Dytuss Elixir may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Dytuss Elixir with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Dytuss Elixir; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Dytuss Elixir may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Do not become overheated in hot weather or while you are being active; heatstroke may occur.

  • Dytuss Elixir may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Dytuss Elixir for a few days before the tests.

  • Some of these products contain phenylalanine. If you must have a diet that is low in phenylalanine, ask your pharmacist if it is in your product.

  • Dytuss Elixir may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Dytuss Elixir. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.

  • Dytuss Elixir has diphenhydramine in it. Before you start any new medicine, check the label to see if it has diphenhydramine in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • If your symptoms persist for more than 1 week or if you develop a fever, contact your health care provider.

  • Do not use Dytuss Elixir for a cough with a lot of mucus. Do not use it for a long-term cough (eg, caused by asthma, emphysema, smoking). However, you may use it for these conditions if your doctor tells you to.

  • Use Dytuss Elixir with caution in the ELDERLY; they may be more sensitive to its effects, especially dizziness, sedation, and lightheadedness upon standing.

  • Different brands of Dytuss Elixir may have different dosing instructions for CHILDREN. Follow the dosing instructions on the package labeling. If your doctor has given you instructions, follow those. If you are unsure of the dose to give a child, check with your doctor or pharmacist.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dytuss Elixir while you are pregnant. Dytuss Elixir is found in breast milk. If you are or will be breast-feeding while you use Dytuss Elixir, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Dytuss Elixir:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dizziness; drowsiness; dry mouth, throat, and nose; excitability; thickening of mucus in nose or throat.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); convulsions; fast heartbeat or pounding in the chest; decreased alertness; hallucinations; tremor; wheezing.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Dytuss side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; excitement; hallucinations; loss of consciousness; muscle twitching; seizures; tremor; weakness.


Proper storage of Dytuss Elixir:

Store Dytuss Elixir at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dytuss Elixir out of the reach of children and away from pets.


General information:


  • If you have any questions about Dytuss Elixir, please talk with your doctor, pharmacist, or other health care provider.

  • Dytuss Elixir is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dytuss Elixir. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dytuss resources


  • Dytuss Side Effects (in more detail)
  • Dytuss Use in Pregnancy & Breastfeeding
  • Dytuss Drug Interactions
  • Dytuss Support Group
  • 0 Reviews for Dytuss - Add your own review/rating


Compare Dytuss with other medications


  • Allergic Reactions
  • Cold Symptoms
  • Cough
  • Extrapyramidal Reaction
  • Hay Fever
  • Insomnia
  • Motion Sickness
  • Nausea/Vomiting
  • Pruritus
  • Urticaria

Flamirex




Flamirex may be available in the countries listed below.


Ingredient matches for Flamirex



Deflazacort

Deflazacort is reported as an ingredient of Flamirex in the following countries:


  • Argentina

International Drug Name Search

Wednesday 23 December 2009

Alexoprine




Alexoprine may be available in the countries listed below.


Ingredient matches for Alexoprine



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Alexoprine in the following countries:


  • Egypt

International Drug Name Search

Tuesday 22 December 2009

Prevepen




Prevepen may be available in the countries listed below.


Ingredient matches for Prevepen



Clemizole Penicillin

Clemizole Penicillin is reported as an ingredient of Prevepen in the following countries:


  • Chile

International Drug Name Search

Monday 21 December 2009

Cefzon




Cefzon may be available in the countries listed below.


Ingredient matches for Cefzon



Cefdinir

Cefdinir is reported as an ingredient of Cefzon in the following countries:


  • Japan

International Drug Name Search

Saturday 19 December 2009

Lifter




Lifter may be available in the countries listed below.


Ingredient matches for Lifter



Sildenafil

Sildenafil citrate (a derivative of Sildenafil) is reported as an ingredient of Lifter in the following countries:


  • Chile

International Drug Name Search

Tuesday 15 December 2009

Caffein Biomed




Caffein Biomed may be available in the countries listed below.


Ingredient matches for Caffein Biomed



Caffeine

Caffeine is reported as an ingredient of Caffein Biomed in the following countries:


  • New Zealand

Caffeine citrate (a derivative of Caffeine) is reported as an ingredient of Caffein Biomed in the following countries:


  • New Zealand

International Drug Name Search

Ampicilina / Sulbactam




Ampicilina/Sulbactam may be available in the countries listed below.


Ingredient matches for Ampicilina/Sulbactam



Ampicillin

Ampicillin is reported as an ingredient of Ampicilina/Sulbactam in the following countries:


  • Colombia

  • Peru

  • Venezuela

Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Ampicilina/Sulbactam in the following countries:


  • Venezuela

Sulbactam

Sulbactam is reported as an ingredient of Ampicilina/Sulbactam in the following countries:


  • Colombia

  • Peru

  • Venezuela

Sulbactam sodium salt (a derivative of Sulbactam) is reported as an ingredient of Ampicilina/Sulbactam in the following countries:


  • Venezuela

International Drug Name Search

Saturday 28 November 2009

PFD




PFD may be available in the countries listed below.


Ingredient matches for PFD



Bentiromide

Bentiromide is reported as an ingredient of PFD in the following countries:


  • Japan

International Drug Name Search

Monday 23 November 2009

Insulin Hypurin Bovine Isophane




Insulin Hypurin Bovine Isophane may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Insulin Hypurin Bovine Isophane



Insulin, Isophane

Insulin, Isophane bovine (a derivative of Insulin, Isophane) is reported as an ingredient of Insulin Hypurin Bovine Isophane in the following countries:


  • United Kingdom

International Drug Name Search

Sunday 22 November 2009

Amoxicillina Union Health




Amoxicillina Union Health may be available in the countries listed below.


Ingredient matches for Amoxicillina Union Health



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina Union Health in the following countries:


  • Italy

International Drug Name Search

Pravastatin Na Mylan




Pravastatin Na Mylan may be available in the countries listed below.


Ingredient matches for Pravastatin Na Mylan



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastatin Na Mylan in the following countries:


  • Japan

International Drug Name Search

Friday 20 November 2009

Erifostine




Erifostine may be available in the countries listed below.


Ingredient matches for Erifostine



Amifostine

Amifostine trihydrate (a derivative of Amifostine) is reported as an ingredient of Erifostine in the following countries:


  • Argentina

International Drug Name Search

Sunday 15 November 2009

Vidarabine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AB03,S01AD06

CAS registry number (Chemical Abstracts Service)

0005536-17-4

Chemical Formula

C10-H13-N5-O4

Molecular Weight

267

Therapeutic Category

Antiviral agent

Chemical Name

9H-Purin-6-amine, 9-ß-D-arabinofuranosyl-

Foreign Names

  • Vidarabinum (Latin)
  • Vidarabin (German)
  • Vidarabine (French)
  • Vidarabina (Spanish)

Generic Names

  • Vidarabine (OS: USAN, DCF, JAN, BAN)
  • Ara-A (IS)
  • CI 673 (IS: Parke-Davis)
  • Vidarabine (PH: USP 32, USP 27)

Brand Names

  • Alase
    Sawai Seiyaku, Japan


  • Araebin
    Pola Pharma, Japan


  • Arasena-A
    Mochida, Japan


  • Armes
    Taiyo Pharmaceutical, Japan


  • Bifubine
    Fuji Yakuhin, Japan


  • Casal
    Shiseido Co., Ltd, Japan


  • Hosrabine
    Iwaki Seiyaku, Japan


  • Silberan
    Maeda Yakuhin, Japan


  • Siosnal
    Towa Yakuhin, Japan


  • Tekarin
    Med-One, Greece


  • Vidarabine
    Alcon, Taiwan


  • Vireprin
    Kleva, Greece

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 13 November 2009

Deflux




Deflux may be available in the countries listed below.


Ingredient matches for Deflux



Domperidone

Domperidone is reported as an ingredient of Deflux in the following countries:


  • Bangladesh

  • Myanmar

International Drug Name Search

Diurex




In some countries, this medicine may only be approved for veterinary use.


In the US, Diurex is a member of the drug class analgesic combinations and is used to treat Period Pain.

Ingredient matches for Diurex



Amiloride

Amiloride hydrochloride dihydrate (a derivative of Amiloride) is reported as an ingredient of Diurex in the following countries:


  • Finland

Ammonium Chloride

Ammonium Chloride is reported as an ingredient of Diurex in the following countries:


  • Australia

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Diurex in the following countries:


  • Argentina

Indapamide

Indapamide is reported as an ingredient of Diurex in the following countries:


  • Colombia

Xipamide

Xipamide is reported as an ingredient of Diurex in the following countries:


  • Spain

International Drug Name Search

Thursday 5 November 2009

Borogal




Borogal may be available in the countries listed below.


Ingredient matches for Borogal



Dexpanthenol

Dexpanthenol is reported as an ingredient of Borogal in the following countries:


  • Bulgaria

International Drug Name Search

Wednesday 28 October 2009

Etomidate




In the US, Etomidate (etomidate systemic) is a member of the drug class general anesthetics.

US matches:

  • Etomidate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N01AX07

CAS registry number (Chemical Abstracts Service)

0033125-97-2

Chemical Formula

C14-H16-N2-O2

Molecular Weight

244

Therapeutic Categories

Agent for procedural sedation

Anesthetic, injectable

Chemical Name

1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)-

Foreign Names

  • Etomidatum (Latin)
  • Etomidat (German)
  • Etomidate (French)
  • Etomidato (Spanish)

Generic Names

  • Etomidate (OS: USAN, BAN)
  • Étomidate (OS: DCF)
  • R 16659 (IS)
  • Etomidat (PH: Ph. Eur. 6)
  • Etomidate (PH: BP 2010, Ph. Eur. 6)
  • Etomidatum (PH: Ph. Eur. 6)

Brand Names

  • Amidate
    Hospira, United States


  • Etomidate
    Bedford, United States; Braun, Latvia; Parenta, United States; PharmaForce, United States


  • Etomidate-Lipuro
    B.Braun, Poland; Braun, Bulgaria; Braun, China; Braun, Estonia; Braun, France; Braun, Hong Kong; Braun, Hungary; Braun, Israel; Braun, Lithuania; Braun, Turkey; Braun, Taiwan


  • Etomidat-Lipuro
    B. Braun Medical, Switzerland; B.Braun, Germany; Braun, Austria; Braun, Israel; Braun, Romania; Braun Melsungen, Luxembourg


  • Etomidato
    Bestpharma, Chile; Braun, Argentina


  • Etomidato-Lipuro
    Braun, Spain


  • Hypnomidate
    Janssen, Belgium; Janssen, Brazil; Janssen, Czech Republic; Janssen, Germany; Janssen, Spain; Janssen, Greece; Janssen, Lebanon; Janssen, Luxembourg; Janssen, Poland; Janssen, Serbia; Janssen, Saudi Arabia; Janssen-Cilag, United Arab Emirates; Janssen-Cilag, Austria; Janssen-Cilag, Bahrain; Janssen-Cilag, France; Janssen-Cilag, United Kingdom; Janssen-Cilag, Turkey; Janssen-Cilag, South Africa; Johnson & Johnson, Croatia (Hrvatska)

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 21 October 2009

Minims Pilocarpine




Minims Pilocarpine may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

UK matches:

  • Minims Pilocarpine Nitrate
  • Minims Pilocarpine Nitrate 2% w/v (SPC)

Ingredient matches for Minims Pilocarpine



Pilocarpine

Pilocarpine hydrochloride (a derivative of Pilocarpine) is reported as an ingredient of Minims Pilocarpine in the following countries:


  • United Kingdom

Pilocarpine nitrate (a derivative of Pilocarpine) is reported as an ingredient of Minims Pilocarpine in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 19 October 2009

Metaraminol Richet




Metaraminol Richet may be available in the countries listed below.


Ingredient matches for Metaraminol Richet



Metaraminol

Metaraminol tartrate (a derivative of Metaraminol) is reported as an ingredient of Metaraminol Richet in the following countries:


  • Argentina

International Drug Name Search

Sunday 18 October 2009

Cabisol




Cabisol may be available in the countries listed below.


Ingredient matches for Cabisol



Benzyl Benzoate

Benzyl Benzoate is reported as an ingredient of Cabisol in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday 13 October 2009

Sefril




Sefril may be available in the countries listed below.


Ingredient matches for Sefril



Cefradine

Cefradine is reported as an ingredient of Sefril in the following countries:


  • Bangladesh

International Drug Name Search

Friday 9 October 2009

Levamisolo




Levamisolo may be available in the countries listed below.


Ingredient matches for Levamisolo



Levamisole

Levamisolo (DCIT) is known as Levamisole in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday 8 October 2009

Ranitidin AL




Ranitidin AL may be available in the countries listed below.


Ingredient matches for Ranitidin AL



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidin AL in the following countries:


  • Germany

International Drug Name Search

Monday 28 September 2009

Micosol




Micosol may be available in the countries listed below.


Ingredient matches for Micosol



Bifonazole

Bifonazole is reported as an ingredient of Micosol in the following countries:


  • Argentina

International Drug Name Search

Friday 25 September 2009

Mirtin




Mirtin may be available in the countries listed below.


Ingredient matches for Mirtin



Mirtazapine

Mirtazapine is reported as an ingredient of Mirtin in the following countries:


  • Denmark

  • Sweden

International Drug Name Search

Wednesday 23 September 2009

Glicerolo + Sodio Cloruro Monico




Glicerolo + Sodio Cloruro Monico may be available in the countries listed below.


Ingredient matches for Glicerolo + Sodio Cloruro Monico



Glycerol

Glycerol is reported as an ingredient of Glicerolo + Sodio Cloruro Monico in the following countries:


  • Italy

International Drug Name Search

Saturday 12 September 2009

Protriptilina




Protriptilina may be available in the countries listed below.


Ingredient matches for Protriptilina



Protriptyline

Protriptilina (DCIT) is known as Protriptyline in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 9 September 2009

Memac Paranova




Memac Paranova may be available in the countries listed below.


Ingredient matches for Memac Paranova



Donepezil

Donepezil hydrochloride (a derivative of Donepezil) is reported as an ingredient of Memac Paranova in the following countries:


  • Denmark

International Drug Name Search

Friday 4 September 2009

Anabact




Anabact may be available in the countries listed below.


Ingredient matches for Anabact



Metronidazole

Metronidazole is reported as an ingredient of Anabact in the following countries:


  • United Kingdom

International Drug Name Search

Tuesday 1 September 2009

Felotens




Felotens may be available in the countries listed below.


UK matches:

  • Felotens XL 10mg Prolonged Release Tablets (SPC)
  • Felotens XL 2.5mg Prolonged Release Tablets (SPC)
  • Felotens XL 5mg Prolonged Release Tablets (SPC)

Ingredient matches for Felotens



Felodipine

Felodipine is reported as an ingredient of Felotens in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 31 August 2009

Pro-Roxikam




Pro-Roxikam may be available in the countries listed below.


Ingredient matches for Pro-Roxikam



Piroxicam

Piroxicam is reported as an ingredient of Pro-Roxikam in the following countries:


  • Bosnia & Herzegowina

  • Czech Republic

International Drug Name Search

Monday 24 August 2009

Serenase Dekanoat




Serenase Dekanoat may be available in the countries listed below.


Ingredient matches for Serenase Dekanoat



Haloperidol

Haloperidol decanoate (a derivative of Haloperidol) is reported as an ingredient of Serenase Dekanoat in the following countries:


  • Denmark

International Drug Name Search

Sunday 23 August 2009

Fungimed




Fungimed may be available in the countries listed below.


Ingredient matches for Fungimed



Fluconazole

Fluconazole is reported as an ingredient of Fungimed in the following countries:


  • Belgium

  • Oman

International Drug Name Search

Tuesday 18 August 2009

Noskapin Dak




Noskapin Dak may be available in the countries listed below.


Ingredient matches for Noskapin Dak



Noscapine

Noscapine hydrochloride (a derivative of Noscapine) is reported as an ingredient of Noskapin Dak in the following countries:


  • Denmark

International Drug Name Search

Friday 14 August 2009

Uft




Uft may be available in the countries listed below.


Ingredient matches for Uft



Tegafur

Tegafur is reported as an ingredient of Uft in the following countries:


  • Austria

  • Belgium

  • Brazil

  • Croatia (Hrvatska)

  • Germany

  • Iceland

  • Israel

  • Japan

  • Netherlands

  • Norway

  • Poland

  • Slovakia

  • South Africa

  • Spain

International Drug Name Search

Tuesday 11 August 2009

Diafuryl




Diafuryl may be available in the countries listed below.


Ingredient matches for Diafuryl



Nifuroxazide

Nifuroxazide is reported as an ingredient of Diafuryl in the following countries:


  • France

  • Turkey

International Drug Name Search

Thursday 6 August 2009

belimumab Intravenous


be-LIM-ue-mab


Commonly used brand name(s)

In the U.S.


  • Benlysta

Available Dosage Forms:


  • Powder for Solution

Pharmacologic Class: Monoclonal Antibody


Uses For belimumab


Belimumab injection is used to treat systemic lupus erythematosus (SLE or lupus) in adults who are also receiving other therapy. It is a monoclonal antibody that changes the immune system to help control lupus symptoms.


belimumab is to be administered only by or under the immediate supervision of your doctor.


Before Using belimumab


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For belimumab, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to belimumab or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of belimumab injection in children. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of belimumab injection in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of belimumab. Make sure you tell your doctor if you have any other medical problems, especially:


  • Depression, history of or

  • Mental illness, history of—Use with caution. May make these conditions worse.

  • Infection or

  • Weak immune system (eg, history of cancer or steroid use)—May decrease your body's ability to fight infection.

Proper Use of belimumab


A nurse or other trained health professional will give you belimumab. belimumab is given through a needle placed in one of your veins.


belimumab must be given slowly, so the needle will remain in place for at least one hour. You may also receive medicines to help prevent possible allergic reactions to the injection.


belimumab comes with a Medication Guide. It is very important that you read and understand this information. Be sure to ask your doctor about anything you do not understand.


Precautions While Using belimumab


It is very important that your doctor check your progress at regular visits to make sure that belimumab is working properly. Blood tests may be needed to check for unwanted effects.


You should not receive belimumab if you are also using cyclophosphamide (Cytoxan®).


Tell your doctor if you are pregnant or if you plan to become pregnant. Women who could potentially get pregnant while receiving belimumab must use an effective form of birth control during therapy and for at least 4 months after the last dose. If you become pregnant while receiving belimumab, your doctor may want you to join a registry for pregnant patients.


belimumab may increase your risk of developing infections. Avoid being near people who are sick while you are receiving belimumab. Wash your hands often. Tell your doctor if you have any kind of infection before you receive the medicine. Also tell your doctor if you have ever had an infection that would not go away or an infection that kept coming back.


Call your doctor right away if you have blurred vision; a cough that won't go away; fever, chills, or flu-like symptoms, such as a runny or stuffy nose; a headache; night sweats; or weight loss. These may be signs that you have an infection.


Belimumab may cause an infustion reaction while you are receiving it or right after the infusion ends. Check with your doctor or nurse right away if you have a headache; itching; dizziness, fainting, or lightheadedness; nausea; muscle or joint pain; or a rash.


belimumab may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Tell your doctor right away if you have chest pain; hives; itching; a rash; swelling of the face, tongue, and throat; or trouble breathing after you receive the medicine.


belimumab may cause some people to be agitated, irritable, or display other abnormal behaviors. It may also cause some people to have suicidal thoughts and tendencies or to become more depressed. If you or your caregiver notice any of these unwanted effects, tell your doctor right away.


While you are being treated with belimumab, and after you stop treatment with it, do not have any immunizations (vaccines) without your doctor's approval. Belimumab may lower your body's resistance and the vaccine may not work as well or you might get the infection the vaccine is meant to prevent. In addition, you should not be around other persons living in your household who receive live virus vaccines because there is a chance they could pass the virus on to you. Some examples of live vaccines include measles, mumps, influenza (nasal flu vaccine), poliovirus (oral form), rotavirus, and rubella. Do not get close to them and do not stay in the same room with them for very long. If you have questions about this, talk to your doctor.


belimumab Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Bladder pain

  • bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the site of injection

  • bloody or cloudy urine

  • body aches or pain

  • chest congestion

  • chills

  • cough

  • cough-producing mucus

  • diarrhea

  • difficult, burning, or painful urination

  • difficulty with breathing or swallowing

  • dizziness

  • ear congestion

  • facial swelling

  • fever

  • frequent urge to urinate

  • general feeling of discomfort or illness

  • headache

  • hives

  • itching, pain, redness, swelling, tenderness, or warmth on the skin

  • joint pain

  • loss of appetite

  • lower back or side pain

  • muscle aches and pains

  • nasal congestion

  • nausea or vomiting

  • pain or tenderness around the eyes and cheekbones

  • reddening of the skin, especially around the ears

  • swelling of the eyes, face, or inside of the nose

  • shivering

  • shortness of breath or troubled breathing

  • skin rash

  • sneezing

  • sore throat

  • stuffy or runny nose

  • sweating

  • tightness in the chest

  • trouble sleeping

  • unusual tiredness or weakness

  • wheezing

Less common
  • Black, tarry stools

  • fast heartbeat

  • hoarseness

  • sores, ulcers, or white spots on the lips or in the mouth

  • swollen glands

  • tender, swollen glands in the neck

  • unusual bleeding or bruising

  • voice changes

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Arm or leg pain

  • sleeplessness

  • unable to sleep

Less common
  • Abdominal or stomach pain

  • depression

  • fear or nervousness

  • headache, severe and throbbing

  • weakness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: belimumab Intravenous side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More belimumab Intravenous resources


  • Belimumab Intravenous Side Effects (in more detail)
  • Belimumab Intravenous Use in Pregnancy & Breastfeeding
  • Belimumab Intravenous Drug Interactions
  • Belimumab Intravenous Support Group
  • 0 Reviews for Belimumab Intravenous - Add your own review/rating


Compare belimumab Intravenous with other medications


  • Systemic Lupus Erythematosus

Wednesday 5 August 2009

Alsol




Alsol may be available in the countries listed below.


Ingredient matches for Alsol



Aluminium Acetotartrate

Aluminium Acetotartrate is reported as an ingredient of Alsol in the following countries:


  • Germany

  • Hungary

International Drug Name Search

Monday 3 August 2009

Alphin




Alphin may be available in the countries listed below.


Ingredient matches for Alphin



Albendazole

Albendazole is reported as an ingredient of Alphin in the following countries:


  • Bangladesh

International Drug Name Search

Friday 31 July 2009

Pixor




Pixor may be available in the countries listed below.


Ingredient matches for Pixor



Salicylic Acid

Salicylic Acid is reported as an ingredient of Pixor in the following countries:


  • Switzerland

Triclosan

Triclosan is reported as an ingredient of Pixor in the following countries:


  • Switzerland

International Drug Name Search

Tuesday 28 July 2009

Pravapharm




Pravapharm may be available in the countries listed below.


Ingredient matches for Pravapharm



Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravapharm in the following countries:


  • Germany

International Drug Name Search

Thursday 16 July 2009

Optiray 350


Generic Name: ioversol (eye oh VERS ol)

Brand Names: Optiray 160, Optiray 240, Optiray 300, Optiray 320, Optiray 350


What is Optiray 350 (ioversol)?

Ioversol is in a group of drugs called radiopaque (RAY dee oh payk) contrast agents. Ioversol contains iodine, a substance that absorbs x-rays. Radiopaque contrast agents are used to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (x-ray) examination.


Ioversol is used to help diagnose certain disorders of the heart, brain, and blood vessels.


Ioversol may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about Optiray 350 (ioversol)?


You should not receive ioversol if you have any type of active infection.

Tell your doctor if you have asthma, hay fever, or history of food or drug allergies, especially if you have had any type of reaction to another contrast agent.


Drink extra fluids before and after you receive ioversol. This medication can cause you to get dehydrated, which can lead to dangerous effects on your kidneys. Follow your doctor's instructions about the types and amount of fluids you should drink before and after your test.

What should I discuss with my health care provider before receiving Optiray 350 (ioversol)?


Tell your doctor if you have ever had any type of reaction to another contrast agent.


You should not receive ioversol if you have any type of active infection.

Before receiving ioversol, tell your doctor if you have:



  • a brain tumor or hematoma;




  • a recent head or brain injury;




  • epilepsy or other seizure disorder;




  • a bleeding or blood clotting disorder;




  • kidney disease;




  • liver disease;




  • diabetes;




  • heart disease, angina, or congestive heart failure;




  • homocysteinuria;




  • sickle cell disease;




  • a history of stroke, blood clots, or circulation problems;




  • asthma, hay fever, or a history of food or drug allergies;




  • multiple myeloma (bone cancer);




  • pheochromocytoma; or




  • a thyroid disorder.



If you have any of these conditions, you may not be able to receive ioversol, or you may need a dosage adjustment or special tests during treatment.


FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether ioversol passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Older adults may need special care in avoiding dehydration by drinking extra fluids before and after the radiologic test. Your kidney function may also need to be watched closely after you have received ioversol.


How is ioversol used?


Ioversol is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting during your radiologic test.


Drink extra fluids before and after you receive ioversol. This medication can cause you to get dehydrated, which can lead to dangerous effects on your kidneys. Follow your doctor's instructions about the types and amount of fluids you should drink before and after your test. Your doctor or other healthcare provider may want to watch you for a short period of time after your injection. This is to make sure you do not have any unwanted side effects or delayed reactions.

This medication can cause you to have unusual results with certain thyroid tests. If you have such tests within 16 days after receiving ioversol, tell the doctor in charge that you have recently received ioversol.


What happens if I miss a dose?


Since ioversol is used only during your radiologic test, you will not be on a dosing schedule.


What happens if I overdose?


Seek emergency medical attention if you think you have received too much of this medicine. Symptoms of an ioversol overdose may include chest pain, trouble breathing, and slow or uneven heartbeats.

What should I avoid while receiving Optiray 350 (ioversol)?


Do not allow yourself to become dehydrated during the first few days after receiving ioversol. Call your doctor if you have any vomiting or diarrhea during this time. Follow your doctor's instructions about the types and amount of fluids you should drink.

Optiray 350 (ioversol) side effects


Some of the side effects of ioversol can occur up to 24 hours after you have received the medication.


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:

  • urinating less than usual or not at all;




  • severe muscle pain or weakness;




  • seizure (convulsions);




  • chest pain or heavy feeling, pain spreading to the arm or shoulder, nausea, sweating, general ill feeling;




  • sudden numbness or weakness, especially on one side of the body;




  • sudden headache, confusion, problems with vision, speech, or balance;




  • feeling light-headed, fainting;




  • wheezing, trouble breathing;




  • fast or slow heartbeat;




  • easy bruising, unusual bleeding, or skin changes; or




  • swelling of your hands, ankles, or feet.



Other less serious side effects are more likely to occur, such as:



  • fever, warmth, or pain;




  • skin rash or redness;




  • headache; or




  • nausea.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Optiray 350 (ioversol)?


There may be other drugs that can affect ioversol. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More Optiray 350 resources


  • Optiray 350 Side Effects (in more detail)
  • Optiray 350 Use in Pregnancy & Breastfeeding
  • Optiray 350 Drug Interactions
  • Optiray 350 Support Group
  • 0 Reviews for Optiray 350 - Add your own review/rating


Compare Optiray 350 with other medications


  • Body Imaging
  • Cerebral Arteriography
  • Coronary Arteriography
  • Head Imaging
  • Intra-arterial Digital Subtraction Angiography
  • Intravenous Digital Subtraction Angiography
  • Intravenous Urography
  • Left Ventriculography
  • Pediatric Angiocardiography
  • Peripheral Arteriography
  • Renal Arteriography
  • Venography
  • Visceral Arteriography


Where can I get more information?


  • Your doctor or pharmacist has more information about ioversol written for health professionals that you may read.

See also: Optiray 350 side effects (in more detail)


Wednesday 15 July 2009

Apomorphin-Archimedes




Apomorphin-Archimedes may be available in the countries listed below.


Ingredient matches for Apomorphin-Archimedes



Apomorphine

Apomorphine hydrochloride (a derivative of Apomorphine) is reported as an ingredient of Apomorphin-Archimedes in the following countries:


  • Germany

International Drug Name Search

Tuesday 14 July 2009

Benzoyl Peroxide Bar


Pronunciation: BEN-zoyl per-OX-ide
Generic Name: Benzoyl Peroxide
Brand Name: Examples include Fostex BPO and PanOxyl


Benzoyl Peroxide Bar is used for:

Treating acne.


Benzoyl Peroxide Bar is a keratolytic agent with antibacterial actions. The effectiveness of benzoyl peroxide appears to be due to its antibacterial, peeling (keratolytic), and drying actions.


Do NOT use Benzoyl Peroxide Bar if:


  • you are allergic to any ingredient in Benzoyl Peroxide Bar

Contact your doctor or health care provider right away if any of these apply to you.



Before using Benzoyl Peroxide Bar:


Some medical conditions may interact with Benzoyl Peroxide Bar. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

Some MEDICINES MAY INTERACT with Benzoyl Peroxide Bar. Because little, if any, of Benzoyl Peroxide Bar is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Benzoyl Peroxide Bar may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Benzoyl Peroxide Bar:


Use Benzoyl Peroxide Bar as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Wash the affected area with Benzoyl Peroxide Bar for 1 to 2 minutes. Rinse thoroughly with water and pat skin dry with a clean towel. Wash your hands after using Benzoyl Peroxide Bar.

  • If you miss a dose of Benzoyl Peroxide Bar, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to you regular dosing schedule.

Ask your health care provider any questions you may have about how to use Benzoyl Peroxide Bar.



Important safety information:


  • Use on the skin only. Avoid getting Benzoyl Peroxide Bar in your eyes, nose, or mouth, on highly inflamed or damaged skin, or on your lips. If you get Benzoyl Peroxide Bar in your eyes, immediately wash them out with cool tap water.

  • Do not apply Benzoyl Peroxide Bar to raw or irritated skin, including sunburns, or to open wounds.

  • Several weeks may pass before you see improvement in your acne. Continue to use Benzoyl Peroxide Bar for the full time recommended by your doctor. If your acne does not improve or if it gets worse, check with your doctor.

  • Talk with your doctor before you use any other medicines, special cleansers, aftershave, or cosmetics on your skin.

  • Benzoyl Peroxide Bar may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Benzoyl Peroxide Bar. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.

  • Benzoyl Peroxide Bar may cause bleaching. Avoid contact with hair, fabrics, or carpeting.

  • Benzoyl Peroxide Bar should be used with extreme caution in CHILDREN younger than 12 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Benzoyl Peroxide Bar while you are pregnant. It is not known if Benzoyl Peroxide Bar is found in breast milk. If you are or will be breast-feeding while you use Benzoyl Peroxide Bar, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Benzoyl Peroxide Bar:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dryness; feeling of warmth; irritation; itching; mild peeling, redness, or swelling of the skin.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; dizziness; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); excessive burning, itching, redness, swelling, or tenderness of your skin; extreme dryness.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Benzoyl Peroxide side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include excessive scaling, flushing, redness, or swelling.


Proper storage of Benzoyl Peroxide Bar:

Store at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in a tightly closed container. Store away from heat and light. Keep Benzoyl Peroxide Bar out of the reach of children and away from pets.


General information:


  • If you have any questions about Benzoyl Peroxide Bar, please talk with your doctor, pharmacist, or other health care provider.

  • Benzoyl Peroxide Bar is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Benzoyl Peroxide Bar. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Benzoyl Peroxide resources


  • Benzoyl Peroxide Side Effects (in more detail)
  • Benzoyl Peroxide Use in Pregnancy & Breastfeeding
  • Benzoyl Peroxide Drug Interactions
  • Benzoyl Peroxide Support Group
  • 15 Reviews for Benzoyl Peroxide - Add your own review/rating


Compare Benzoyl Peroxide with other medications


  • Acne
  • Perioral Dermatitis

Monday 6 July 2009

Diclofenac Rapid ratiopharm




Diclofenac Rapid ratiopharm may be available in the countries listed below.


Ingredient matches for Diclofenac Rapid ratiopharm



Diclofenac

Diclofenac is reported as an ingredient of Diclofenac Rapid ratiopharm in the following countries:


  • Denmark

International Drug Name Search

Sunday 5 July 2009

Lomef




Lomef may be available in the countries listed below.


Ingredient matches for Lomef



Lomefloxacin

Lomefloxacin hydrochloride (a derivative of Lomefloxacin) is reported as an ingredient of Lomef in the following countries:


  • India

International Drug Name Search

Sunday 28 June 2009

Marcaine




In the US, Marcaine (bupivacaine systemic) is a member of the drug class local injectable anesthetics and is used to treat Cesarean Section and Local Anesthesia.

US matches:

  • Marcaine Solution

  • Marcaine Spinal Solution

  • Marcaine HCl

  • Marcaine Spinal

Ingredient matches for Marcaine



Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Marcaine in the following countries:


  • Bahrain

  • Belgium

  • Canada

  • Cyprus

  • Czech Republic

  • Egypt

  • Estonia

  • Georgia

  • Ghana

  • Guyana

  • Iraq

  • Israel

  • Jordan

  • Kenya

  • Kuwait

  • Latvia

  • Lebanon

  • Libya

  • Luxembourg

  • Malawi

  • Mozambique

  • Netherlands

  • Nigeria

  • Oman

  • Poland

  • Qatar

  • Romania

  • Saudi Arabia

  • Serbia

  • Slovenia

  • Sudan

  • Syria

  • Taiwan

  • Tanzania

  • Turkey

  • Uganda

  • United Arab Emirates

  • United States

  • Yemen

  • Zambia

  • Zimbabwe

International Drug Name Search

Tuesday 23 June 2009

Berodual




Berodual may be available in the countries listed below.


Ingredient matches for Berodual



Fenoterol

Fenoterol is reported as an ingredient of Berodual in the following countries:


  • Slovakia

Fenoterol hydrobromide (a derivative of Fenoterol) is reported as an ingredient of Berodual in the following countries:


  • Austria

  • Colombia

  • Germany

  • Hungary

  • Indonesia

  • Netherlands

  • Poland

  • Singapore

  • Slovenia

  • Switzerland

  • Vietnam

Ipratropium

Ipratropium Bromide is reported as an ingredient of Berodual in the following countries:


  • Austria

  • Colombia

  • Denmark

  • Germany

  • Hungary

  • Indonesia

  • Netherlands

  • Poland

  • Singapore

  • Slovakia

  • Slovenia

  • Switzerland

  • Vietnam

International Drug Name Search

Tuesday 9 June 2009

Eliprim




Eliprim may be available in the countries listed below.


Ingredient matches for Eliprim



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Eliprim in the following countries:


  • Peru

Trimethoprim

Trimethoprim is reported as an ingredient of Eliprim in the following countries:


  • Peru

International Drug Name Search

Monday 8 June 2009

Novo-Venlafaxine




Novo-Venlafaxine may be available in the countries listed below.


Ingredient matches for Novo-Venlafaxine



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Novo-Venlafaxine in the following countries:


  • Canada

International Drug Name Search

Friday 22 May 2009

Doc Budeso




Doc Budeso may be available in the countries listed below.


Ingredient matches for Doc Budeso



Budesonide

Budesonide is reported as an ingredient of Doc Budeso in the following countries:


  • Luxembourg

International Drug Name Search

Saturday 9 May 2009

Lax Tabs




Lax Tabs may be available in the countries listed below.


Ingredient matches for Lax Tabs



Bisacodyl

Bisacodyl is reported as an ingredient of Lax Tabs in the following countries:


  • New Zealand

International Drug Name Search

Thursday 7 May 2009

Dalacin T Prewash




Dalacin T Prewash may be available in the countries listed below.


Ingredient matches for Dalacin T Prewash



Triclosan

Triclosan is reported as an ingredient of Dalacin T Prewash in the following countries:


  • New Zealand

International Drug Name Search

Tuesday 5 May 2009

Dilast




Dilast may be available in the countries listed below.


Ingredient matches for Dilast



Torasemide

Torasemide is reported as an ingredient of Dilast in the following countries:


  • Bangladesh

International Drug Name Search

Monday 4 May 2009

Fenicort




Fenicort may be available in the countries listed below.


Ingredient matches for Fenicort



Prednisolone

Prednisolone 21-(sodium tetrahydrophthalate) (a derivative of Prednisolone) is reported as an ingredient of Fenicort in the following countries:


  • Poland

International Drug Name Search

Sunday 3 May 2009

Durezol


Generic Name: difluprednate ophthalmic (DYE floo PRED nate off THAL mik)

Brand Names: Durezol


What is difluprednate ophthalmic?

Difluprednate is a steroid medicine. It prevents the release of substances in the body that cause inflammation.


Difluprednate ophthalmic (for the eye) is used to treat eye swelling caused by surgery.

Difluprednate ophthalmic may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about difluprednate ophthalmic?


You should not use this medication if you are allergic to difluprednate, or if you have any type of viral or fungal eye infection, ocular herpes, or an untreated infection in your eye or elsewhere, including chickenpox.

Before using difluprednate ophthalmic, tell your doctor if you are allergic to any drugs, or if you have herpes. You may need a dose adjustment or special tests to safely use difluprednate.


Do not allow the dropper tip to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.


Do not stop using difluprednate suddenly without first talking to your doctor. Tell your doctor if your symptoms do not improve after 2 days of treatment with difluprednate ophthalmic.


Do not wear any contact lens that has not been approved by your doctor. Do not use difluprednate ophthalmic while you are wearing regular contact lenses. This medication may contain a preservative that can be absorbed by soft contact lenses and cause discoloration. Wait at least 15 minutes after using difluprednate before putting your contact lenses in.

Do not use any other eye medications unless your doctor has prescribed them.


What should I discuss with my healthcare provider before I receive difluprednate ophthalmic?


You should not use this medication if you are allergic to difluprednate, or if you have any type of infection, especially:

  • a fungal or bacterial eye infection;




  • any type of viral eye infection, such as ocular herpes; or




  • an untreated infection in your eye or elsewhere, including chickenpox.



Before using difluprednate ophthalmic, tell your doctor if you are allergic to any drugs, or if you have herpes. You may need a dose adjustment or special tests to safely use difluprednate.


FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether difluprednate ophthalmic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use difluprednate ophthalmic?


Use this medication exactly as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


Difluprednate ophthalmic is usually given 4 times per day beginning 24 hours after your surgery and continuing for 2 weeks. After the first 2 weeks, your dose may be decreased to 2 times per day for 1 week or longer. Follow your doctor's instructions.


Wash your hands before using the eye drops.

To apply the eye drops:



  • Tilt your head back slightly and pull down your lower eyelid to create a small pocket. Hold the dropper above the eye with the dropper tip down. Look up and away from the dropper as you squeeze out a drop, then close your eye.




  • Gently press your finger to the inside corner of the eye (near your nose) for about 1 minute to keep the liquid from draining into your tear duct.




  • Use the eye drops only in the eye you are having surgery on.




  • Do not allow the dropper tip to touch any surface, including the eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.




Tell your doctor if your symptoms do not improve after 2 days of treatment with difluprednate ophthalmic. Do not stop using difluprednate suddenly without first talking to your doctor. You may need to use less and less before you stop the medication completely.

To be sure this medication is not causing harmful effects, your eyes may need to be checked on a regular basis. Do not miss any scheduled visits to your doctor.


Store this medication at room temperature away from heat, moisture, and light. Do not freeze. Keep the bottle tightly closed when not in use.

What happens if I miss a dose?


Use the medication as soon as you remember the missed dose. If it is almost time for your next dose, skip the missed dose and use the medicine at your next regularly scheduled time. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

An overdose of difluprednate is not likely to cause life-threatening symptoms.


What should I avoid after I receive difluprednate ophthalmic?


Do not wear any contact lens that has not been approved by your doctor.

Do not use difluprednate ophthalmic while you are wearing regular contact lenses. This medication may contain a preservative that can be absorbed by soft contact lenses and cause discoloration. Wait at least 15 minutes after using difluprednate before putting your contact lenses in.


Do not use any other eye medications unless your doctor has prescribed them.


Difluprednate can cause side effects that may impair your vision. Be careful if you drive or do anything that requires you to see clearly.

Difluprednate ophthalmic side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as:

  • pain behind your eyes, sudden vision changes, severe headache;




  • sudden eye irritation;




  • blurred vision, tunnel vision, eye pain, or seeing halos around lights; or




  • signs of new eye infection, such as swelling, draining, or crusting of your eyes.



Less serious side effects may include mild burning, stinging, or itching of your eyes.



  • feeling like something is in your eye;




  • eyes being more sensitive to light;




  • eye pain, itching, or redness; or




  • itchy or watery eyes.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect difluprednate ophthalmic?


It is not likely that other drugs you take orally or inject will have an effect on difluprednate ophthalmic used in the eyes. But many drugs can interact with each other. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Durezol resources


  • Durezol Side Effects (in more detail)
  • Durezol Dosage
  • Durezol Use in Pregnancy & Breastfeeding
  • Durezol Support Group
  • 0 Reviews for Durezol - Add your own review/rating


  • Durezol Prescribing Information (FDA)

  • Durezol Monograph (AHFS DI)

  • Durezol Advanced Consumer (Micromedex) - Includes Dosage Information

  • Durezol Emulsion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Durezol Consumer Overview



Compare Durezol with other medications


  • Postoperative Ocular Inflammation


Where can I get more information?


  • Your doctor or pharmacist can provide more information about difluprednate ophthalmic.

See also: Durezol side effects (in more detail)


Saturday 25 April 2009

Lestmart N




Lestmart N may be available in the countries listed below.


Ingredient matches for Lestmart N



Nicergoline

Nicergoline is reported as an ingredient of Lestmart N in the following countries:


  • Japan

International Drug Name Search

Thursday 23 April 2009

Gabex




Gabex may be available in the countries listed below.


Ingredient matches for Gabex



Gabapentin

Gabapentin is reported as an ingredient of Gabex in the following countries:


  • Chile

International Drug Name Search

Wednesday 15 April 2009

CO OP Tylosin 40 / Sulfamethazine




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for CO OP Tylosin 40 / Sulfamethazine



Sulfadimidine

Sulfadimidine is reported as an ingredient of CO OP Tylosin 40 / Sulfamethazine in the following countries:


  • United States

Tylosin

Tylosin phosphate (a derivative of Tylosin) is reported as an ingredient of CO OP Tylosin 40 / Sulfamethazine in the following countries:


  • United States

International Drug Name Search

Alprazolam Kern Pharma




Alprazolam Kern Pharma may be available in the countries listed below.


Ingredient matches for Alprazolam Kern Pharma



Alprazolam

Alprazolam is reported as an ingredient of Alprazolam Kern Pharma in the following countries:


  • Spain

International Drug Name Search

Thursday 26 March 2009

Youcobal




Youcobal may be available in the countries listed below.


Ingredient matches for Youcobal



Mecobalamin

Mecobalamin is reported as an ingredient of Youcobal in the following countries:


  • Japan

International Drug Name Search

Benox




Benox may be available in the countries listed below.


Ingredient matches for Benox



Oxybuprocaine

Oxybuprocaine hydrochloride (a derivative of Oxybuprocaine) is reported as an ingredient of Benox in the following countries:


  • Egypt

  • Iraq

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Oman

  • Qatar

  • Saudi Arabia

  • Sudan

  • United Arab Emirates

  • Yemen

International Drug Name Search

Rhinabid


Generic Name: brompheniramine and phenylephrine (BROM fen IR a meen and FEN il EFF rin)

Brand Names: Alacol, Alenaze-D, Alenaze-D NR, B-Vex D, BPM PE, Brom Tann PE, Bromfed, Bromfed-PD Capsules, BroveX ADT, BroveX PEB, Brovex-D, Children's Cold & Allergy, Dimaphen Elixir, Dimetapp Cold & Allergy, Entre-B, J-Tan D, J-Tan D SR, Phenyl 15/12mg, Phenyl 7.5/6mg, RespaHist II, Rhinabid, Rhinabid PD, Seradex-LA, Tanabid SR, V-Hist, VazoBid, VaZol-D, Vazotab, Zotex-PE


What is Rhinabid (brompheniramine and phenylephrine)?

Brompheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of brompheniramine and phenylephrine is used to treat nasal congestion, sneezing, itching, watery eyes, and runny nose caused by allergies, hay fever, and the common cold.


Brompheniramine and phenylephrine may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Rhinabid (brompheniramine and phenylephrine)?


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. You should not use this medication if you are allergic to brompheniramine or phenylephrine, or to other decongestants, diet pills, stimulants, or ADHD medications. Do not use brompheniramine and phenylephrine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Ask a doctor or pharmacist about taking brompheniramine and phenylephrine if you have heart disease or high blood pressure, diabetes, a thyroid disorder, glaucoma, kidney disease, an enlarged prostate, or problems with urination.


What should I discuss with my healthcare provider before taking Rhinabid (brompheniramine and phenylephrine)?


You should not use this medication if you are allergic to brompheniramine or phenylephrine, or to other decongestants, diet pills, stimulants, or ADHD medications. Do not use brompheniramine and phenylephrine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Ask a doctor or pharmacist if it is safe for you to take brompheniramine and phenylephrine if you have:



  • heart disease or high blood pressure;




  • diabetes;




  • a thyroid disorder;




  • glaucoma;




  • kidney disease;




  • an enlarged prostate; or




  • problems with urination.




FDA pregnancy category C. It is not known whether brompheniramine and phenylephrine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Brompheniramine and phenylephrine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I take Rhinabid (brompheniramine and phenylephrine)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Cough or cold medicine is usually taken only for a short time until your symptoms clear up.


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Take the medicine with a full glass of water. Do not crush, chew, break, or open an extended-release capsule. Swallow it whole. Breaking or opening the pill may cause too much of the drug to be released at one time.

The chewable tablet must be chewed before you swallow it.


Measure liquid medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Shake the oral suspension (liquid) well just before you measure a dose. Do not take brompheniramine and phenylephrine for longer than 7 days in a row. Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash. Store at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include feeling restless or nervous, nausea, vomiting, stomach pain, dizziness, drowsiness, dry mouth, warmth or tingly feeling, or seizure (convulsions).


What should I avoid while taking Rhinabid (brompheniramine and phenylephrine)?


This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.

Avoid becoming overheated or dehydrated during exercise and in hot weather.


Drinking alcohol can increase certain side effects of brompheniramine and phenylephrine. Ask a doctor or pharmacist before using any other cold, cough, allergy, or pain medicine. Antihistamines and decongestants are contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains an antihistamine or decongestant.

Avoid taking this medication if you also take diet pills, caffeine pills, or other stimulants (such as ADHD medications). Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


Rhinabid (brompheniramine and phenylephrine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have a serious side effect such as:

  • fast, pounding, or uneven heartbeat;




  • severe dizziness, anxiety, restless feeling, or nervousness;




  • easy bruising or bleeding, unusual weakness, fever, chills, body aches, flu symptoms;




  • nausea, upper stomach pain, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or




  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats, seizure).



Less serious side effects may include:



  • drowsiness or dizziness;




  • blurred vision;




  • dry mouth, nose, or throat;




  • mild stomach pain, constipation;




  • problems with memory or concentration;




  • feeling restless or excited (especially in children);




  • sleep problems (insomnia); or




  • warmth, redness, or tingly feeling under your skin.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Rhinabid (brompheniramine and phenylephrine)?


Before using brompheniramine and phenylephrine, tell your doctor if you regularly use other medicines that make you sleepy (such as cold or allergy medicine, sedatives, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). They can add to sleepiness caused by brompheniramine and phenylephrine.

Tell your doctor about all other medications you are using, especially:



  • medicines to treat high blood pressure;




  • a beta blocker such as atenolol (Tenormin, Tenoretic), carvedilol (Coreg), labetalol (Normodyne, Trandate), metoprolol (Dutoprol, Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal, InnoPran), sotalol (Betapace), and others; or




  • antidepressants such as amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Janimine, Tofranil), and others.



This list is not complete and other drugs may interact with brompheniramine and phenylephrine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Rhinabid resources


  • Rhinabid Side Effects (in more detail)
  • Rhinabid Use in Pregnancy & Breastfeeding
  • Rhinabid Drug Interactions
  • Rhinabid Support Group
  • 0 Reviews for Rhinabid - Add your own review/rating


  • Rhinabid Sustained-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Alenaze-D Elixir MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bromfed MedFacts Consumer Leaflet (Wolters Kluwer)

  • BroveX-D Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Entre-B Prescribing Information (FDA)

  • J-Tan D Chewable Tablets MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Rhinabid with other medications


  • Hay Fever
  • Nasal Congestion
  • Rhinitis


Where can I get more information?


  • Your pharmacist can provide more information about brompheniramine and phenylephrine.

See also: Rhinabid side effects (in more detail)